19 June 2013
Keywords: BTG, Wellstat, Uridine, 5-FU overexposure antidote
Article | 06 July 2011
UK specialist health care company BTG (LSE: BGC) has acquired US commercial rights to US privately-held Wellstat Therapeutics’s ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 July 2011
18 June 2013
© 2013 thepharmaletter.com